BackNovoCure Overview

NovoCure Inventory

NovoCure's inventory is $42M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$42.22M
↑ 5.01% YoYΔ $2.01M vs prior year quarter

Peer trimmed avg / median

Loading

NovoCure Inventory History

Loading

NovoCure vs. peers: Inventory Comparison

Loading

NovoCure Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NovoCure (NVCR) FAQ

NovoCure (NVCR) currently reports a inventory of $42M as of June 2026. That compares with $40M in the prior-year period — up 5.0% year over year. Use the charts on this page to explore NovoCure's inventory history and peer comparisons.

NovoCure's inventory increased from $40M to $42M — a 5.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NovoCure reported $42M in inventory as of June 2026. That compares with $40M in the prior-year period — up 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NovoCure, and consider following NVCR for alerts when major investors trade the stock.

NovoCure is classified in the Healthcare sector. On inventory, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVCR with unrelated industries.